FABP12 and posterior cortical atrophy: Treatment of FABP12-expressing cells with a CPT1 inhibitor (inhibits the formation of acyl carnitines used for β-oxidation) inhibits both FABP12-induced mitochondrial β-oxidation and cell migration [29], suggesting a role for FABP12 in promoting PCa cell invasive properties via enhanced lipid-derived bioenergetics.